| Item # |
Category |
Title of Standard |
Reference Number and Date |
Effective Date |
Standards Development Organization |
| 3 |
InVitro |
Assessment of the Clinical Accuracy of Laboratory Tests Using Receiver Operating Characteristic (ROC) Plots; Approved Guideline |
GP10-A 1995 |
11/03/2006 |
CLSI NCCLS |
| 4 |
InVitro |
Labeling of Home-Use In Vitro Testing Products; Approved Guideline |
GP14-A 1996 |
11/03/2006 |
CLSI NCCLS |
| 6 |
InVitro |
Specifications for Immunological Testing for Infectious Diseases; Approved Guideline |
I/LA18-A 1994 |
02/19/1998 |
NCCLS |
| 7 |
InVitro |
Assessing the Quality of Radioimmunoassay Systems - Second Edition; Approved Guideline |
LA1-A2 1994 |
11/03/2006 |
CLSI NCCLS |
| 11 |
InVitro |
Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline |
MM3-A 1995 |
02/19/1998 |
NCCLS |
| 12 |
InVitro |
Definitions of Quantities and Conventions Related to Blood pH and Gas Analysis; Approved Standard (1994) |
C12-A |
11/03/2006 |
CLSI NCCLS |
| 13 |
InVitro |
Performance Characteristics for Devices Measuring PO2 and PCO2 in Blood Samples; Approved Standard (1992) |
C21-A |
11/03/2006 |
CLSI NCCLS |
| 15 |
InVitro |
Fractional Oxyhemoglobin, Oxygen Content and Saturation, and Related Quantities in Blood: Terminology, Measurement, and Reporting; Approved Guideline (1997) |
C25-A |
11/03/2006 |
CLSI NCCLS |
| 16 |
InVitro |
Blood Gas Preanalytical Considerations: Specimen Collection, Calibration, and Controls; Approved Guideline (1993) |
C27-A |
11/03/2006 |
CLSI NCCLS |
| 18 |
InVitro |
Ancillary (Bedside) Blood Glucose Testing |
C30-A |
11/03/2006 |
CLSI NCCLS |
| 21 |
InVitro |
Erythrocyte Protoporphyrin Testing; Approved Guideline (1996) |
C42-A |
08/14/1998 |
NCCLS |
| 22 |
InVitro |
Fine-Needle Aspiration Biopsy (FNAB) Techniques; Approved Guideline (1996) |
GP20-A |
08/14/1998 |
NCCLS |
| 25 |
InVitro |
Detection of Abnormal Hemoglobin Using Cellulose Acetate Electrophoresis - Second Edition; Approved Standard (1994) |
H8-A2 |
08/14/1998 |
NCCLS |
| 26 |
InVitro |
Chromatographic (Microcolumn) Determination of Hemoglobin A2; Approved Standard (1989) |
H9-A |
08/14/1998 |
NCCLS |
| 27 |
InVitro |
Solubility Test to Confirm the Presence of Sickling Hemoglobins - Second Edition; Approved Standard (1995) |
H10-A2 |
08/14/1998 |
NCCLS |
| 29 |
InVitro |
Devices for Collection of Skin Puncture Blood Specimens - Second Edition; Approved Guideline (1990) |
H14-A2 |
08/14/1998 |
NCCLS |
| 31 |
InVitro |
Reference Leucocyte Differential Count (Proportional) and Evaluation of Instrumental Methods; Approved Standard (1992) |
H20-A |
08/14/1998 |
NCCLS |
| 34 |
InVitro |
Methods for Reticulocyte Counting (Flow Cytometry and Supravital Dyes); Approved Guideline (1997) |
H44-A |
08/14/1998 |
NCCLS |
| 35 |
InVitro |
One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline (1996) |
H47-A |
08/14/1998 |
NCCLS |
| 36 |
InVitro |
Quality Assurance for the Indirect Immunoflurescence Test for Autoantibodies to Nuclear Antigen (IF-ANA); Approved Guideline (1996) |
I/LA2-A |
08/14/1998 |
NCCLS |
| 37 |
InVitro |
Detection and Quantitation of Rubella IGG Antibody: Evaluation and Performance Criteria for Multiple Component Test Products, Specimen Handling, and Use of Test Products in the Clinical Laboratory; Approved Guideline (1997) |
I/LA6-A |
08/14/1998 |
NCCLS |
| 38 |
InVitro |
Choriogonadotropin Testing: Nomenclature, Reference Preparations, Assay Performance, and Clinical Application; Approved Guideline (1996) |
I/LA10-A |
11/03/2006 |
CLSI NCCLS |
| 39 |
InVitro |
Assessing the Quality of Systems for Alpha-Fetoprotein (AFP) Assays Used in Prenatal Screening and Diagnosis of Neural Tube Defects; Approved Guideline (1997) |
I/LA17-A |
11/03/2006 |
CLSI NCCLS |
| 40 |
InVitro |
Specifications for Immunological Testing for Infectious Diseases; Approved Guideline (1994) |
I/LA18-A |
08/14/1998 |
NCCLS |
| 41 |
InVitro |
Primary Reference Preparations Used to Standardize Calibration of Immunochemical Assays for Serum Prostate Specific Antigen (PSA); Approved Guideline (1997) |
I/LA19-A |
08/14/1998 |
NCCLS |
| 42 |
InVitro |
Evaluation Methods and Analytical Performance Characteristics of Immunological Assays for Human Immunoglobulin E (IgE) Antibodies of Defined Allergen Specificities; Approved Guideline (1997) |
I/LA20-A |
08/14/1998 |
NCCLS |
| 43 |
InVitro |
Blood Collection on Filter Paper for Neonatal Screening Programs; Approved Standard - Third Edition (1997) |
LA4-A3 |
11/03/2006 |
CLSI NCCLS |
| 46 |
InVitro |
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard (1997) |
M27-A |
08/14/1998 |
NCCLS |
| 48 |
InVitro |
Blood Alcohol Testing in the Clinical Laboratory; Approved Guideline (1997) |
T/DM6-A |
11/03/2006 |
CLSI NCCLS |
| 49 |
InVitro |
Performance Goals for the Internal Quality Control of Multichannel Hematology Analyzers; Approved Standard |
H26-A |
05/03/1999 |
NCCLS |
| 50 |
InVitro |
Glossary and Guidance for Immunodiagnostic Procedures, Reagents, and Reference Materials - Second Edition, Approved Guideline |
D11-A2 |
05/03/1999 |
NCCLS |
| 51 |
InVitro |
Using Proficiency Testing (PT) to Improve the Clinical Laboratory; Approved Guideline |
GP 27-A |
11/03/2006 |
CLSI NCCLS |
| 52 |
InVitro |
Terminology and Definitions for use in NCCLS Documents; Approved Standard |
NRSCL 8-A |
11/03/2006 |
CLSI NCCLS |
| 53 |
InVitro |
Continuous Quality Improvement: Essential Management Approaches; Approved Guideline |
GP 22-A |
05/03/1999 |
NCCLS |
| 54 |
InVitro |
Immunoprecipitin Analyses: Procedures for Evaluating the Performance of Materials - Second Edition; Approved Guideline |
D12-A2 |
10/31/2005 |
CLSI |
| 55 |
InVitro |
Procedures for the Handling and Processing of Blood Specimens; Approved Guideline -- Second Edition |
H18-A2 |
11/03/2006 |
CLSI NCCLS |
| 58 |
InVitro |
Procedures for the Collection of Arterial Blood Specimens; Approved Standard - Third Edition |
H11-A3 |
10/01/2001 |
NCCLS |
| 59 |
InVitro |
Laboratory Automation: Bar Codes for Specimen Container Identification; Approved Standard |
AUTO2-A |
11/03/2006 |
CLSI NCCLS |
| 60 |
InVitro |
Laboratory Automation: Specimen Container/Specimen Carrier; Approved Standard |
AUTO1-A |
10/01/2001 |
NCCLS |
| 61 |
InVitro |
Laboratory Automation: Communications with Automated Clinical Laboratory Systems, Instruments, Devices, and Information Systems; Approved Standard |
AUTO3-A |
10/01/2001 |
NCCLS |
| 62 |
InVitro |
Laboratory Automation: Systems Operational Requirements, Characteristics, and Information Elements; Approved Standard |
AUTO4-A |
05/31/2002 |
NCCLS |
| 63 |
InVitro |
Laboratory Automation: Electromechanical Interfaces; Approved Standard |
AUTO5-A |
05/31/2002 |
NCCLS |
| 64 |
InVitro |
Point-of-Care Connectivity; Approved Standard |
POCT1-A |
05/31/2002 |
NCCLS |
| 67 |
InVitro |
Evaluation of Matrix Effects; Approved Guideline |
EP14-A |
03/11/2003 |
NCCLS |
| 68 |
InVitro |
Laboratory Instruments and Data Management Systems: Design of Software User Interfaces and End-User Software Systems Validation, Operation, and Monitoring; Approved Guideline - Second Edition |
GP19-A2 |
03/11/2003 |
NCCLS |
| 70 |
InVitro |
Procedures and Devices for the Collection of Diagnostic Blood Specimens by Skin Puncture; Approved Standard - Fourth Edition |
H4-A4 |
03/11/2003 |
NCCLS |
| 71 |
InVitro |
Reference and Selected Procedures for the Quantitative Determination of Hemoglobin in Blood; Approved Standard - Third Edition |
H15-A3 |
03/11/2003 |
NCCLS |
| 72 |
InVitro |
Clinical Application of Flow Cytometry: Quality Assurance and Immunophenotyping of Lymphocytes; Approved Guideline |
H42-A |
03/11/2003 |
NCCLS |
| 73 |
InVitro |
Clinical Evaluation of Immunoassays; Approved Guideline |
I/LA21-A |
03/11/2003 |
NCCLS |
| 74 |
InVitro |
Protocols for Evaluating Dehydrated Mueller-Hinton Agar; Approved Standard |
M6-A |
03/11/2003 |
NCCLS |
| 76 |
InVitro |
Laboratory Diagnosis of Blood-borne Parasitic Diseases; Approved Guideline |
M15-A |
03/11/2003 |
NCCLS |
| 77 |
InVitro |
Quality Assurance for Commerically Prepared Microbiological Culture Media - Second Edition; Approved Standard |
M22-A2 |
03/11/2003 |
NCCLS |
| 78 |
InVitro |
Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline |
M23-A2 |
03/11/2003 |
NCCLS |
| 79 |
InVitro |
Procedures for the Recovery and Identification of Parasites from the Intestinal Tract; Approved Guideline |
M28-A |
03/11/2003 |
NCCLS |
| 80 |
InVitro |
Molecular Diagnostic Methods for Genetic Diseases; Approved Guideline |
MM1-A |
03/11/2003 |
NCCLS |
| 81 |
InVitro |
How to Define and Determine Reference Intervals in the Clinical Laboratory; Approved Guideline - Second Edition |
C28-A2 |
03/11/2003 |
NCCLS |
| 82 |
InVitro |
Sweat Testing: Collection and Quantitative Analysis; Approved Guideline - Second Edition |
C34-A2 |
03/11/2003 |
NCCLS |
| 83 |
InVitro |
Blood Gas and pH Analysis and Related Measurements; Approved Guideline |
C46-A |
03/11/2003 |
NCCLS |
| 84 |
InVitro |
Stability Testing of In Vitro Diagnostic Reagents |
13640 |
06/01/2004 |
CEN |
| 85 |
InVitro |
Statistical Quality Control for Quantitative Measurements: Principles and Definitions: Approved Guideline - Second Edition (1999): ISBN 1-56238-371-X |
C24-A2 |
03/08/2004 |
NCCLS |
| 86 |
InVitro |
Standardization of Sodium and Potassium Ion Selective Electrode Systems to the Flame Photometric Reference Method; Approved Standard (2000) ISBN 1-56238-406-6 |
C29-A2 |
03/08/2004 |
NCCLS |
| 87 |
InVitro |
Ionized Calcium Determinations: Precollection Variables, Specimen Choice, Collection, and Handling; Approved Guideline - Second Edition (2001); ISBN 1-56238-436-8 |
C31-A2 |
03/08/2004 |
NCCLS |
| 88 |
InVitro |
Preparation and Validation of Commutable Frozen Human Serum Pools as Secondary Reference Materials for Cholesterol Measurement Procedures; Approved Guideline |
C37-A |
03/08/2004 |
NCCLS |
| 89 |
InVitro |
A Designated Comparison Method for the Measurement of Ionized Calcium in Serum; Approved Standard (2000) ISBN1-56238-398-1 |
C39-A |
03/08/2004 |
NCCLS |
| 90 |
InVitro |
Clinical Applications of Flow Cytometry: Immunophenotyping of Leukemic Cells; Approved Guideline |
H43-A |
03/08/2004 |
NCCLS |
| 92 |
InVitro |
Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline |
EP09-A2 |
03/08/2004 |
NCCLS |
| 93 |
InVitro |
Preliminary Evaluation of Quantitative Clinical Laboratory Methods; Approved Guideline |
EP10-A2 |
03/08/2004 |
NCCLS |
| 94 |
InVitro |
User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline |
EP12-A |
03/08/2004 |
NCCLS |
| 95 |
InVitro |
User Demonstration of Performance for Precision and Accuracy; Approved Guideline |
EP15-A |
03/08/2004 |
NCCLS |
| 96 |
InVitro |
Quality Management for Unit-Use Testing; Approved Guideline |
EP18-A |
03/08/2004 |
NCCLS |
| 97 |
InVitro |
Urinalysis and Collection, Transportation, and Preservation of Urine Specimens - Second Edition; Approved Guideline |
GP16-A2 |
03/08/2004 |
NCCLS |
| 98 |
InVitro |
Immunoglobulin and T-Cell Receptor Gene Rearrangement Assays; Approved Guideline-2nd Edition |
MM2-A |
06/01/2004 |
NCCLS |
| 99 |
InVitro |
Nucleic Acid Amplification Assays for Molecular Hematopathology; Approved Guideline |
MM5-A |
06/01/2004 |
NCCLS |
| 100 |
InVitro |
In vitro diagnostic test systems - Requirements for in vitro whole blood glucose monitoring systems intended for use by patients for self testing in management of diabetes mellitus, First Edition 2003-05-01, Approved |
15197 |
06/01/2004 |
ISO |
| 101 |
InVitro |
Assays of vonWillebrand Factor Antigen and Ristocetin Cofactor Activity; Approved Guideline |
H51-A |
06/01/2004 |
NCCLS |
| 102 |
InVitro |
Tubes and Additives for Venous Blood Specimen Collection; Approved Standard |
H1-A5 |
09/01/2004 |
NCCLS |
| 103 |
InVitro |
Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard |
H3-A5 |
09/01/2004 |
NCCLS |
| 104 |
InVitro |
Procedure for Determining Packed Cell Volume by the Microhematocrit Method - Second Edition; Approved Standard - Third Edition |
H7-A3 |
09/01/2004 |
NCCLS |
| 105 |
InVitro |
Procedure for the Determination of Fibrinogen in Plasma; Approved Guideline Second Edition |
H30-A2 |
09/01/2004 |
NCCLS |
| 106 |
InVitro |
Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - 8th Edition |
M2-A8 |
09/01/2004 |
NCCLS |
| 107 |
InVitro |
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically`; Approved Standard - Sixth Edition |
M11-A6 |
09/01/2004 |
NCCLS |
| 108 |
InVitro |
Methods for Antimicrobial Susceptibility Tests of Anaerobic Bacteria; Approved Standard -- Sixth Edition |
M7-A6 |
09/01/2004 |
NCCLS |
| 109 |
InVitro |
Laboratory Automation: Data Content for Specimen Identification; Approved Standard |
AUTO7-A |
10/31/2005 |
CLSI |
| 110 |
InVitro |
Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline-Second Edition |
EP5-A2 |
10/31/2005 |
CLSI |
| 111 |
InVitro |
Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays; Approved Guideline - Fourth Edition |
H21-A4 |
10/31/2005 |
CLSI |
| 112 |
InVitro |
Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline |
H49-A |
10/31/2005 |
CLSI |
| 113 |
InVitro |
Assessing the Quality of Immunoassay Systems: Radioimmunoassays, and Enzyme, Fluorescence, and Luminescence Immunoassays; Approved Guidelines |
I/LA23-A |
10/31/2005 |
CLSI |
| 114 |
InVitro |
Standard Specification for Low-Level Protocol to Transfer Messages Between Clinical Laboratory Instruments and Computer Systems |
LIS01-A |
10/31/2005 |
CLSI |
| 115 |
InVitro |
Standard Specification for Transferring Information Between Clinical Instruments and Computer Systems; Approved Standard-Second Edition |
LIS02-A2 |
10/31/2005 |
CLSI |
| 116 |
InVitro |
Standard Guide for Selection of a Clinical Laboratory Information Management System |
LIS03-A |
10/31/2005 |
CLSI |
| 117 |
InVitro |
Standard Guide for Documentation of Clinical Laboratory Computer Systems |
LIS04-A |
10/31/2005 |
CLSI |
| 118 |
InVitro |
Standand Specification for Transferring Clinical Observations Between Independent Computer Systems |
LIS05-A |
10/31/2005 |
CLSI |
| 119 |
InVitro |
Standard Practice for Reporting Reliability of Clinical Laboratory Information Systems |
LIS06-A |
10/31/2005 |
CLSI |
| 120 |
InVitro |
Standard Specification for Use of Bar Codes on Specimen Tubes in the Clinical Laboratory |
LIS07-A |
10/31/2005 |
CLSI |
| 121 |
InVitro |
Standard Guide for Functional Requirements of Clinical Laboratory Information Management Systems |
LIS08-A |
10/31/2005 |
CLSI |
| 122 |
InVitro |
Standard Guide for Coordination of Clinical Laboratory Services within the Electronic Health Record Environment and Networked Architectures |
LIS09-A |
10/31/2005 |
CLSI |
| 123 |
InVitro |
Nucleic Acid Sequencing Methods in Diagnostic Laboratory Medicine |
MM9-A |
10/31/2005 |
CLSI |
| 124 |
InVitro |
Fluorescence Calibration and Quantitative Measurement of Fluorescence Intensity; Approved Guideline |
I/LA24-A |
11/03/2006 |
CLSI NCCLS |
| 125 |
InVitro |
Procedures for the Recovery and Identification of Parasites from the Intestinal Tract; Approved Guideline |
M28-A2, Volume 25, No. 16 |
11/03/2006 |
CLSI NCCLS |
| 126 |
InVitro |
Susceptibility Testing of Mycobacteria, Nocardiae and other Aerobic Actinomycetes |
M24-A, Volume 23, No.18: |
11/03/2006 |
CLSI NCCLS |
| 127 |
InVitro |
Interference Testing in Clinical Chemistry; Approved Guideline - Second Edition |
EP 7-A2 |
05/21/2007 |
NCCLS |
| 128 |
InVitro |
Evaluation of Matrix Effects; Approved Guideline - Second Edition |
EP14-A2 |
05/21/2007 |
CLSI |
| 129 |
InVitro |
Quality Control of Microbiological Transport Systems |
M40-A |
05/21/2007 |
CLSI |